Equibactin vet contains sulfadiazine and trimethoprim, and is indicated for use in the treatment of infections, particularly respiratory tract infections associated with Streptococcus spp. and Staphylococcus aureus; gastrointestinal infections associated with E. coli; urogenital infections associated with beta-hemolytic streptococci; and wound infections and open or drained abscesses associated with Streptococcus spp. and Staphylococcus aureus.
The new product has been designed to provide accurate administration to all sizes of horses or ponies. One syringe provides a complete dose for 600kg bodyweight and is subdivided into 12 markings, to help keep track of dosages.
Dechra Brand Manager Emma Jennings said: "Equibactin vet has a proven antibiotic combination with a synergistic effect2 making it an excellent first line broad spectrum antimicrobial treatment for most Gram positive and negative aerobes.
It can be administered without food which improves the oral bioavailability, offering equine veterinary surgeons a quick and efficient treatment when it comes to targeting these infections that are often experienced in day-to-day practice.
"With its ease of use and three-year shelf life, we anticipate that Equibactin vet will quickly become a popular product when it comes to maintaining equine health."
For more information, visit www.dechra.co.uk/products/equine.
References
The nurse, who admitted the charges against her, successfully applied for anonymity at the outset of the case, on the basis that the shock factor of the removal of the animals' heads could greatly upset members of the public and veterinary staff, leading to a backlash which would present a threat to her safety.
The Disciplinary Committee heard that the nurse, who was working as a locum, asked a permanent member of staff if she could take a couple of skulls from the strays, because she had a friend who 'cleaned up' dead strays and wildlife and displayed the skulls at home.
The College’s case was that the nurse’s actions amounted to serious professional misconduct because she failed to afford the dead animals with the respect and dignity they deserved, there was a risk to human health because she failed to comply with biosecurity measures, and her actions had the potential to undermine public confidence in the profession.
Although she admitted that her conduct fell short of what was expected, the nurse countered that her actions were not intended to be disrespectful to the animals, that she was an animal-lover who had three cats of her own, and that her actions were not malicious but misjudged.
Weighing up the case, the Committee found that the aggravating features of her conduct were around biosecurity and abuse of her professional position, while in mitigation it found that there was no financial gain in her actions and that it was a one-off incident.
Kathryn Peaty, chairing the Committee and speaking on its behalf, said: “The respondent’s conduct represented a biosecurity risk.
"Any body part would be in some degree of decomposition.
"As the cats were strays, it was unclear as to whether or not they had been in good health.
"Although the respondent transferred the body parts to her home and kept them in the freezer in cadaver bags, there was a risk that they could leak.
"In short, her actions were not without risk to human or animal health.
“The respondent abused her professional position.
"She had an obligation to treat the cadavers with respect.
"Her professional position gave her access to the cadavers.
"She abused her professional position by severing the cats’ heads and, using a scalpel, body bags and other equipment she pursued an interest of her own, rather than performed the role she was employed to undertake.
"Although she may say that she obtained permission to remove the cats’ heads from a permanent member of staff, she was a Registered Veterinary Nurse and therefore an autonomous professional.
"Whatever permissions she received should not have made her believe she had a licence to act as she did.”
Considering the appropriate sanction, the Committee took into account her relative youth and inexperience, the fact she made open and frank admissions at an early stage, the fact she made efforts to avoid a repetition of the behaviours, the insight she had shown into why her conduct was wrong, and the amount of time that had passed since her conduct relative to the total length of her four-year veterinary nursing career.
The Committee also considered positive character references from fellow veterinary nurses with whom she worked and trained.
Kathryn added: “The Committee considered that a reprimand was the sanction it should impose.
"A reprimand marks the Committee’s view of the respondent’s behaviour, thereby satisfying the public interest.
“The Committee did consider issuing a warning as to future conduct, but it had no concerns that the respondent would fail to follow the Code of Professional Conduct for Veterinary Nurses in the future.
"It therefore rejected a warning as an appropriate alternative.”
The full findings of the Disciplinary Committee can be found at www.rcvs.org.uk/disciplinary
Eurovet Animal Health has announced that it is bringing a veterinary licensed vitamin K1 (phytomenadione) injectable preparation to the UK.
Eurovet says the new preparation, available from the wholesalers by Monday at the latest, will ensure that the previous supply problems of vitamin K1, will be overcome.
According to the company, the intravenous route is the only route to ensure a 100% bioavailability of vitamin K1 almost immediately and in a crisis situation is the best route of treatment. During anticoagulant poisoning, the coagulation factors are present in the body but are not functional. The faster vitamin K1 enters the blood flow, the quicker the coagulation function is restored.
Ruth Vernon, Technical Services Manager for Eurovet said: "We also plan to bring veterinary licenced vitamin K1 tablets to the UK market later in the year, allowing them to be ordered direct from veterinary wholesalers. The future continuity of supply represents a significant improvement on the current situation."
Anticoagulant rodenticide poisoning is the second most common query received by the VPIS. Alexander Campbell, Head of Service at VPIS, said: "The Veterinary Poisons Information Service receives well over 1000 telephone enquiries per annum from UK veterinary professionals seeking advice on how to manage potential and accidental exposures to anticoagulant rodenticides in a variety of animals - mainly pet dogs. Whilst most cases require basic assessment, first-aid and precautionary laboratory tests, an inevitable few develop serious intoxication and need long-term treatment. Vitamin K1 is a mainstay of therapy in these instances, and the availability of licensed veterinary-specific products in the UK is a major advance. Previously, preparations licensed for human use were often the only option when these could be sourced. Anything that ensures ready supply and facilitates speed of therapy for severe cases has to be welcomed."
There are over 500 anticoagulant rodent killing preparations available across Europe. They are available ready to use, as coated cereals, bait blocks, tracking powders, semolina formats or concentrates (which are reserved for professional use). Following cut backs in local council spending on pest control, the National Pest Technicians Association identified in a recent survey* that there is a 'worrying increase in poorly-managed DIY rodent control'.
*The NPTA National Rodent Survey 2009/2010
Ceva says the new product is the fruit of research into the composition of the main feline pheromones which pass through the incisive ducts to the Vomeronasal Organ (VNO), which in turn led to the discovery of a new pheromone complex which 'provides an enhanced message of social confidence and safety in the cat’s environment by conveying more impactful messages to it'.
According to the company, Feliway Optimum helps cats with more signs of stress, in more situations and calms cats better than ever. The product is proven to help with more stress-related signs faster than existing pheromones, with all signs of stress showing continuous improvement until day 28 of use and are visible from day 71. These include scratching, urine spraying, multi-cat tensions and conflicts and changes and fears.
Feliway Optimum is available as a plug-in diffuser with 30-day refills.
Abigail King, senior behaviour product manager at Ceva Animal Health said: "We have led the way with research for over 20 years with Feliway Classic and Feliway Friends, but it is now time to go that step further.
"Feliway Optimum is an extremely exciting addition to the range which will help solve all common signs of stress to provide enhanced serenity in a household.
"Nearly 60 per cent of cats show visible signs of stress2 and Feliway Optimum will really help combat this with an over 70% reduction”.
There is a webinar about the new product, presented by Professor Patrick Pageat and Dr Andy Sparkes, which is available by emailing Ceva.
For more information, visit www.feliway.com/uk, call Ceva on 01494 781510 or email cevauk@ceva.com.
The review was recommended to Council by its Standards Committee following its exploration of the implications of new technologies for both animal health and welfare and veterinary regulation.
The main areas under consideration are the interpretation and application of an animal being under the care of a veterinary surgeon, and the provision of 24-hour emergency cover.
The College says that during the course of its research, which included numerous meetings and reports, a public consultation and examination of external legal advice, the Committee identified a number of anomalies in the College’s existing guidance that could affect how the Code’s provisions were applied across a range of different scenarios.
Chair of the Standards Committee, Dr Kate Richards, said: "It became clear to us that we could not consider telemedicine and remote prescribing in isolation and that it raised broader questions around the appropriateness of, and justification for, certain elements of existing RCVS guidance. I’m therefore pleased that RCVS Council has decided that the right and responsible approach is first to conduct a full review of these provisions."
The College anticipates that the review will require wide engagement from all relevant sectors, potentially including a Select Committee-style hearing in certain areas. This, it says, would help to ensure any decision to treat different groups differently, in relation to 'under care' and 'out-of-hours', is both reasoned and justified.
In the meantime, the College says that the current provisions of the RCVS Code of Professional Conduct and its supporting guidance remain in full effect.
Further information about the review will be made available in due course.
UPDATE (19/06/2019)
Following a number of concerns raised by members of the profession about this story, the RCVS has issued a further statement as follows:
We would like to acknowledge and address a number of concerns that have arisen amongst the profession following RCVS Council’s discussion last week that followed up queries raised during the previous debate in November, around the provision of telemedicine services, including remote prescribing.
The RCVS Council decision, made unanimously, was to proceed with a wide-ranging review of RCVS supporting guidance concerning 24-hour emergency cover and the interpretation and application of ‘under veterinary care’, and to postpone the proposed telemedicine trial for the foreseeable future and certainly until the conclusion of this review. The review will encompass, but not be limited to, consideration of what restrictions or safeguards to place on remote prescribing in the form of vet-to-client telemedicine.
RCVS Council discussed this paper ‘in committee’ in order to be able to examine the confidential legal advice it had requested at its previous meeting. The decision to hold these discussions privately was purely related to the privileged nature of legal advice and in no way related to any ‘commercial interests’.
We recognise fully that this is a complex issue, with strong views held on all sides. However, it is entirely right and proper for RCVS Council members to be able to discuss and debate such topics in detail, before reaching a decision through a vote. In the course of such discussions, issues may arise that had not previously been identified, and which may alter the original direction of thinking.
We appreciate that Council’s decision was perhaps unexpected, especially as the original topic had been under consideration for some time. This is why we announced it as soon as possible, along with an indication of what Council would like to happen next.
Whilst it is far too early to have worked out the details of the agreed review, it will be open and inclusive in parallel with our previous consultations, which continue to receive considerable levels of engagement across the veterinary professions and wider industry stakeholders.
We will publish full details about our plans for this review over the coming weeks, and will continue to work hard to engage all veterinary professionals in these important decisions.
Billed as an essential reference, the new guide gives practical information on pain management in a wide range of small animals, emphasizing patient welfare and evidence-based medicine.
The BSAVA Guide to Pain Management in Small Animal Practice is edited by Ian Self, an RCVS and European Specialist in Veterinary Anaesthesia and Analgesia.
Each chapter is written by a specialist in the field, and the guide includes 'Authors’ perspectives' and case examples.
The first six chapters cover key areas in pain management, including the physiology of pain, acute and chronic pain, and pharmacological and physical treatment of pain. The remaining chapters look at specific types of pain, and pain in species commonly encountered in small animal practice.
Ian said: "This Guide is not to be seen as an instruction manual, rather a helping hand. For each case discussed and analgesic approach explained, there are multiple valid alternative approaches… when seeking inspiration or information when faced with a patient in pain, we hope that the information presented here will assist in reaching a satisfactory clinical outcome."
The new book will be given to eligible vet and vet nurse members free of charge as part of the Association's loyalty scheme; a 'thank you' for staying a member for another year. Further details are available from the member benefits section of the BSAVA website.
The Disciplinary Committee has directed that Kfir Segev be restored to the RCVS Register, having removed him over two years ago for dishonesty and misleading clients.
Mr Segev, formerly practising in Stanmore, Middlesex, was removed from the Register following an 11-day hearing ending on 19 May 2009 at which he had been proven guilty of deliberately concealing from his clients that their dog was terminally ill, whilst at the same time recommending that she undergo expensive and unnecessary procedures.
This was Mr Segev’s first application for restoration to the Register. The Committee found that, during his period of removal, he had undergone “extensive personal and professional rehabilitation”, which included attendance at a clinical psychologist and voluntary work in the local community.
The Committee found that, during his period of removal, he had undergone "extensive personal and professional rehabilitation.
From 2009 to September 2011, Mr Segev logged 420 hours of certificated continuing professional development, with particular emphasis on ethics, client relationships and animal welfare.
The Committee noted he had also seen practice and taken the advice of mentors, including about 80 days at “a number of high quality practices with eminent members of the profession”.
These included Professor Dick White MRCVS, of Dick White Referrals, Professor David Noakes FRCVS, Emeritus Professor of the Royal Veterinary College and Mr David Grant MBE FRCVS, Hospital Director at the RSCPA Sir Harold Harmsworth Memorial Hospital, all of whom gave evidence at the hearing in support of Mr Segev.
Professor White said that, since late 2009 when he was approached by Mr Segev for help in remedial training, continuing education and mentoring, he had subsequently had frequent dealings and conversations with him.
Professor White said: “I formed the opinion that he invariably exercised professional clinical judgement that is, if anything, considerably deeper than many professional colleagues. I felt he demonstrated compassion for patients and empathy for owners in equal measure and believed him to have come to understand fully the seriousness of his behaviour."
Mr Segev’s efforts at rehabilitation were described as “exceptional” by Professor Noakes, who said he was “impressed by Mr Segev’s genuine acceptance of the fact that he had committed a serious offence and deserved to be punished.”
Mr Grant, who had been in contact with Mr Segev since November 2010, told the hearing that, in his opinion, it was most evident that Mr Segev accepted his wrongdoing and, along with Professor Noakes, indicated that he was willing to offer continued support and help.
The College opposed the restoration of Mr Segev on three grounds, namely: the gravity of the matters found proved at the original hearing; that the length of time off the Register was insufficient to mark these and ensure that the reputation of the profession was not undermined in the eyes of the public; and, Mr Segev’s conduct, relying on two matters arising from the footage in a BBC Panorama programme, which was filmed both before and after the 2009 hearing.
The College also questioned whether Mr Segev genuinely accepted the original findings.
The Committee agreed that the findings of the original hearing were serious; it was, however, impressed by Mr Segev’s complete and genuine written and public apologies for what he had done.
It disagreed that the length of time off the Register was too short.
It was mindful that the purpose of the sanction of erasure is not primarily of punishment and considered that no useful purpose would be served by delaying further Mr Segev’s restoration.
Whilst the Committee found Mr Segev was wrong to have continued to display ‘veterinary surgeon’ on the practice nameplate (as shown in the television footage), it was satisfied that he did not intend to hold himself out as a practising veterinary surgeon and no harm to the public or animal welfare resulted from his mistake.
The footage also showed Mr Segev was in breach of RCVS guidance on the administration of anaesthesia by permitting a student veterinary nurse to induce anaesthesia by using incremental doses of intravenous propofol, with an unqualified assistant offering advice on the depth of anaesthesia during its incremental induction. The Committee considered Mr Segev’s actions to be an error, now cured.
In conclusion, the Committee accepted Mr Segev “had made genuine and successful attempts to reform his previous attitude and failings”.
It noted that a large number of testimonials had been provided by colleagues, friends and clients, and that the impact of removal on Mr Segev had been severe.
It concluded that his previous mistakes provided “no reason, relevant to animal welfare, to suggest that his restoration would be unwise.”
Speaking on behalf of the Committee, Chairman Beverley Cottrell said: “Restoration to the Register of a veterinary surgeon who has been guilty of disgraceful conduct in a professional respect of such seriousness is not something to be undertaken lightly … But, in all the circumstances of this case, [we have] decided that Mr Segev is a fit person to restore to the Register, and so direct the Registrar.”
All members of the practice team are invited to nominate their receptionist, as are members of the public. Nominations should highlight the dedication and effort the nominee demonstrates, and entries need to be in by the 31st January 2019.
BVRA founder Brian Faulkner MRCVS said: "Veterinary receptionists are as crucial to the success of a veterinary practice as any other role. They are first and last impression a client has of a veterinary practice and the association is keen to recognise and reward their unique contribution to the industry.
We’ve been astounded by how popular the BVRA has been since its launch one year ago with receptionists at every level of experience, reporting appreciation as well as the benefits of Accredited Veterinary Receptionist Award. It’s entirely appropriate that BVRA champions ‘best practice’ and therefore the BVRA’s Veterinary Receptionist of the Year Award will recognise their hard work."
Brian added: "We’re so grateful to all of our corporate sponsors in helping us get BVRA off the ground and grow. We are especially grateful to Feliway and Adaptil, sponsors of The Veterinary Receptionist of the Year Award. A motivated and inspired veterinary receptionist can be the difference between whether a client registers with your practice or not. So why not log onto the www.bvra.co.uk right now and nominate that receptionist who deserves to be acknowledged and celebrated?"
Three finalists will be chosen and invited to attend BVRA’s 2nd Annual congress on 16th March 2019 in Sutton Coldfield, where the winner will be announced.
To nominate your receptionist, visit: https://www.bvra.co.uk/Home/CPD.
The ideal Christmas present for a vet to give a child has just landed on my desk.
It's the Amazing ABC Adventure by Lorna Maxwell, out now in paperback from Long Barn Books and available on Amazon here.
Each letter of the alphabet begins an eclectic list of things to be found within a delightful illustration on the facing page. There's a strong animal theme throughout the book: everything from annoyed armadillos and affectionate alligators to worried wombats and yodelling yaks.
One of those books that it's a pleasure to read a child before bed. A steal at £5.79.
Veteran campaigner and RCVS Councillor Danny Chambers MRCVS (pictured right) has started a petition to George Eustice on change.org that: Future trade deals must not compromise animal welfare and public health.
The petition has gathered an impressive 21,984 signatures, of which Danny says that more than 500 are from veterinary surgeons.
Meanwhile VetPartners is calling on the retail and food service sector to give priority to British produce, even if future trade deals enable the import of foods produced to lower standards.
Ian Cure, farm director at VetPartners, is contacting the UK’s main retailers to discuss how they can support British farmers in the months and years to come. He has the backing of the clinical directors at each of the 28 farm or mixed practices within the group, which collectively look after the health and welfare of over 30% of the UK’s dairy population and 45% of the pig population.
“We are asking retailers to prioritise a range of Red Tractor certified produce at varying prices, while avoiding designating shelf space to imports of a lower quality. Likewise, the food service sector can choose to source from UK food supply chains.
“These sectors have a high level of influence, as consumers will pick from what is clearly available, which is why we see it as the best way to support our farmers.
“We are incredibly concerned about how the higher welfare and production standards in UK agriculture will be protected long term, given that MPs failed to enshrine that protection in law when voting against the recent amendment to the Agriculture Bill last month.
“Future trade deals to allow the import of cheap food from countries outside of the EU would be a step in the wrong direction, as our farmers will not be competing on an even playing field as they attempt to compete with countries with lower costs of production.”
However, Ian adds that this is not just a welfare issue: "If the UK livestock sector is forced to adopt practices that are frowned upon in Europe to compete, such as the American applications of hormone growth treatments and chlorinated chicken, we would be severely risking our local, lucrative European export market.
“While trade with countries such as the USA and Australia may have benefits from an economical perspective, the carbon emissions associated with longer distance transport of food is a real concern.
“We see it as imperative that higher welfare standards are maintained, while reducing the carbon footprint of our food supply – it's the right, sustainable thing to do. As MPs have let down the sector, we are now calling on retailers and the food service industry to back UK farming."
The Disciplinary Committee heard that Mrs Garfield had told a representative of the Retired Greyhound Trust (RGT) that she had possession of a greyhound called Lola, that she proposed keeping Lola living with her as an adoptee, and that she would not relinquish possession of Lola except to the RGT. This was despite the fact that, at the time of signing the adoption agreement, she had already given Lola to another charity named Greyhound Gap and that, as a result, her conduct was misleading and dishonest.
In considering the facts of the case, the Committee found the charges and all constituent parts proven and went on to consider whether this amounted to disgraceful conduct in a professional respect.
Judith Way, chairing the Committee and speaking on its behalf, said: "The end result of the respondent’s decisions and conduct meant that RGT was persuaded to pass lawful possession and ownership of the dog Lola to the respondent when it would not have agreed to do so had it been told the truth by her.
"In truth, the respondent was not going to adopt and re-home Lola herself. Instead the respondent’s plan and intention was that Lola should be passed on to a third party who had been recommended by a rival dog rescue charity for rehome and adoption."
Judith added: "The consequence was that a social media dispute broke out when the rival dog charity decided to attempt to take advantage of the erroneous belief of the respondent that a decision had been taken by RGT to put Lola to sleep. The publicity generated by the respondent’s erroneous belief… was obviously adverse…. The gravamen [seriousness] of the respondent’s dishonest conduct was that she set one dog rescue charity against another, caused them to spend publicly raised funds on a legal dispute about who should be allowed to retain Lola when those precious funds ought, instead, to have been spent on their charitable objectives."
The Committee judged that the charge and its parts constituted serious professional misconduct and went on to consider the sanction against Mrs Garfield.
In considering the proportionate sanction the Committee took into account both mitigating and aggravating factors. In terms of aggravating factors the Committee considered that the dishonesty was pre-meditated, that she accused members of a rescue charity of lying and demonstrated no or only minimal insight into her wrongdoing. In mitigation the Committee considered that Mrs Garfield had cooperated with the College in its investigations, that she had acted in the genuine belief that she was acting in the best interests of Lola and that her conduct did not put Lola at risk or cause her to suffer any adverse consequences as a result. The Committee also accepted the testimonials and positive evidence from colleagues.
However, the Committee decided that removal from the Register would be the only appropriate sanction.
Summing up Judith Way said: "The reputational consequences for RGT were potentially significant bearing in mind that it is a rescue organisation with some 57 or so branches across the country. All of these consequences, actual and potential, stem from the respondent’s premeditated act of dishonesty in relation to which the Committee considers she showed very limited insight prior to this disciplinary hearing, as she did during the course of this hearing.
"In the result, it is the conclusion and decision of this Committee that the only proper sanction that can be imposed in this case is that the respondent’s name should be removed from the Register.”
Mrs Garfield has 28 days from being informed of the Committee’s decision to appeal.
The company says that Daxocox achieves significant improvement of clinical signs associated with the pain of osteoarthritis (OA) in dogs1,2 and also helps reduce the risk of breakthrough pain.
Breakthrough pain is defined as “an abrupt, short-lived, and intense pain that breaks through the analgesia that controls pain”3. Risk factors for breakthrough pain in cases of canine OA include poor owner compliance, variable plasma drug levels between doses, natural or exercise induced flare-ups and disease progression.
According to research carried out by the company, veterinary surgeons estimate that nearly half of their canine OA cases on daily NSAIDs experience breakthrough pain4, whilst owners put the figure much higher at 80%5.
Animalcare says that as well as compromising patient welfare and increasing the risk of clinical consequences such as wind-up pain (hypersensitisation), breakthrough pain risks owners losing confidence in their vet and/or the recommended treatment plan for their dog. This may lead owners to independently stray from the treatment plan, with potentially damaging consequences. In its research, 87% of vets agreed that avoiding breakthrough pain is critical to the management of canine OA4.
Animalcare adds that because of the pharmacology, there is no risk of risk of over-accumulation or need for mandatory treatment ‘breaks’6. Also, adverse effects were found to be no different from any other NSAID1,2 and there was no increase in treatment-related adverse effects at up to 5 times the recommended dose7, so Daxocox has a broad margin of safety and is well tolerated by dogs7.
James Beaumont, marketing manager at Animalcare said: “Daxocox’s weekly administration of a flavoured tablet addresses some of the challenges of managing canine OA that I’m certain most vets will identify with. Breakthrough pain is a real problem and by being able to provide consistent pain control, in a compliance friendly formulation, Daxocox is a real game changer for canine OA management.
For more information, visit: www.animalcare.co.uk, or contact your local Animalcare territory manager, or Animalcare’s head office on 01904 487687.
References:
Norbrook has announced the launch of Marbodex Aural, the most recent addition to its Otitis Management System for dogs.
Norbrook says the ingredients in Marbodex Aural (marbofloxacin, clotrimazole, dexamethasone) are proven to relieve pain and inflammation quickly, deal with key bacterial and fungal infections effectively and thereby improve pet comfort.
The company says the inclusion of marbofloxacin makes Marbodex Aural an ideal first choice for cases of otitis externa that are:
Marbodex Aural also contains clotrimazole, a broad spectrum antifungal effective against otitis caused by Malassezia pachydermatis, and dexamethasone, a fast acting steroid whose absorption is not increased in inflamed ears.
Marbodex Aural is applied once a day and has two soft nozzles to reduce pain on application and prevent cross-contamination during treatment. It can be used for extended treatment periods of seven to fourteen days when treating persistent infections.
Marbodex Aural is available in all veterinary wholesalers now. For more information about Marbodex and to take advantage of the launch offers, contact your Norbrook Territory Manager or call 01536 741147 for more information.
Reference:
Dechra Veterinary Products has launched Myorelax, a guaifenesin 100 mg/ml solution for infusion for horses which, the company says, relaxes skeletal muscles within minutes.
Dechra's Equine Brand Manager Emma Jennings said: "Myorelax is indicated for the induction of muscle relaxation and immobilisation, as an adjunct to balanced anaesthesia.
"We're delighted to launch this product, which can be combined with a number of sedatives and anaesthetics including detomidine, ketamine and propofol plus local and volatile anaesthetics.
"Myorelax is a centrally acting muscle relaxant which is effective within a few minutes and does not affect the animal's respiratory muscles at therapeutic doses. It can be used in combination with a sedative and local anaesthetics for short procedures and together with appropriate general anaesthetics for induction and maintenance of muscle relaxation during anaesthesia."
Dechra says that horses are able to stand within 45 minutes after single administration, and the product can be used in a 'triple drip' protocol for total intravenous anaesthesia.
Myorelax is available in 500 ml bottles from veterinary wholesalers.
For further information, visit www.dechra.co.uk
Asked why the CMA had decided to launch the review, its Senior Director for Consumer Protection told BBC R4's Today programme this morning that: "the costs of many vet services are rising higher than the cost of inflation, and it can be really hard to find out how much it's going to cost you, both for routine treatments or if something goes wrong and you need to find emergency care for your pet."
George added: "There's many other [veterinary] services and costs that people cannot have predicted and they can find themselves unexpectedly facing some really high bills, and when other household bills are going up very steeply at the moment we want to do everything we can to make sure that people can predict how much it is going to cost to see a vet, both for routine stuff but also for things if there's a crisis."
The authority is also looking at whether there is enough transparency over practice ownership.
With the percentage of independent practices falling from 89% in 2013 to 45% by 2021, the authority says people may not be clear if their vet is part of a group which owns other vet practices in their area or that the services which are being sold to them (such as diagnostic tests or treatments at a specialist animal hospital) are provided by that group.
This, it says, could impact pet owners’ choices and reduce the incentives of local vet practices to compete.
The CMA is now asking veterinary professionals, people who supply veterinary products and services and pet owners to take part in the review by completing an online questionnaire: https://www.gov.uk/guidance/how-to-respond-to-the-veterinary-services-market-for-pets-review
In particular, it wants to hear practitioners' experiences of:
The questionnaire will remain open for six weeks.
The CMA will outline the issues it identifies and announce its next steps early in 2024.
The study “Evaluation of quick sequential organ failure scores in dogs with severe sepsis and septic shock1” reviewed electronic records from dogs that presented through the veterinary medical teaching hospital emergency service between January 2010 and December 2019 using the search terms “sepsis” or “septic”.
The quick sequential organ failure score was calculated by evaluating respiratory rate (>22 breaths per minute), arterial systolic blood pressure (≤100mmHg) and altered mentation.
Forty-five dogs with severe sepsis and septic shock and 45 dogs with non-infectious systemic inflammatory response syndrome were included in the final analysis.
It was found that the quick sequential organ failure assessment score provided poor discrimination between survivors and non-survivors for dogs with severe sepsis and septic shock.
In addition, the quick sequential organ failure score demonstrated a poor sensitivity and fair specificity to detect this population of canine patients.
The authors say that previous studies on quick sequential organ failure score have provided conflicting results, but that this may just be due to the inherent heterogeneity of the population.
Considering the results of this study, it may not be possible to identify a single scoring system that serves the purpose that quick sequential organ failure assessment is intended for.
Nicola Di Girolamo, Editor of the JSAP said: “The results of this study have strong clinical implications.
"The JSAP values studies with negative findings such as this one, as much as studies with positive findings.
"The fact that a diagnostic tool or a treatment does not reach the desired objective, should not hinder publication of methodologically sound research”
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jsap.13522
Reference
The company warned last year that Equip Artervac would be out of stock from the end of November 2017 until mid-2018, but says that the re-availability of the vaccine means many vaccinated stallions and teasers should now be able to have their six-monthly booster dose within the normal designated timeframe.
Equip Artervac is indicated for the active immunisation for horses against equine arteritis virus to reduce the clinical signs and shedding of virus in nasal secretions following infection.
For further information, contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 choosing option 1.
Novartis Animal Health has announced the launch of Strenzen, an oral water medication for pigs, indicated for the treatment of gastrointestinal infections caused by Escherichia coli, Clostridium perfringens and Salmonella Typhimurium, and for respiratory tract infections caused by Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Strenzen contains contains a combination of amoxicillin trihydrate (500 mg/g) and potassium clavulanate (125 mg/g) in ratio of 4:1. Novartis says it is ideally suited for the treatment of post-weaning infections in pigs.
According to the company, the combination of amoxicillin and clavulanic acid broadens the performance of amoxicillin1,2, especially against resistant strains of bacteria capable of producing ß-lactamase enzymes. Certain bacteria are able to produce ß-lactamase enzymes as a protection mechanism, making the amoxicillin molecule ineffective against them. The clavulanic acid in Strenzen binds to the molecules of the ß-lactamase enzyme, ensuring the amoxicillin remains unaffected and free to attack bacteria. Prof. Dominiek Maes, DVM, MSc, MS, PhD, Dipl. ECVPH, Dipl. ECPHM, from the Porcine Health Management Unit of the Ghent University, Belgium said: "Weaning is a stressful event for piglets and there are several opportunistic diseases that can impact them during this period. The challenge with E. coli and S. suis infections is that in many countries there are currently no commercial vaccines available with proper efficacy. I believe Strenzen can indeed be very helpful in managing those infections which are so prevalent after weaning."
Novartis says Strenzen is rapidly excreted, leading to a withdrawal period of one day, which in turn maximizes production flexibility for pig producers. In addition, the water-soluble formulation of Strenzen ensures that treated pigs get a therapeutic dose even when they stop eating, making it an ideal treatment for sick pigs with compromised appetites.
Recent field trials on infected farms in Spain and the Czech Republic demonstrated that Strenzen-treated pigs give better production performance, better economic returns and require less medical intervention3,4,5. The reduction of the overall amount of antibiotics needed to treat severe post-weaning infections not only saves producers the costs of the labour and the medication, but is also important in regard to the development of resistance in bacteria.
Dr. Ulrich Klein, Global Technical Services Manager, Novartis Animal Health said: "With the launch of Strenzen, Novartis Animal Health demonstrates its commitment to continually broadening our product portfolio to address the specific needs of farmers and food producers. Strenzen has the ideal spectrum for the treatment of post-weaning infections, delivering better productivity results than current therapies for those infections."
On 23rd October, Dr Hannah Capon MA Vet MB MRCVS will present 'OA management: more than just drugs', in which she will consider how best to manage canine osteoarthritis in first opinion practice and offer practical tips on how veterinary surgeons and nurses can help owners manage the condition better.
On 6th November, Dr Zoe Belshaw MA Vet MB PhD Cert SAM Dip ECVIM-CA AFHEA MRCVS (pictured right) will present 'Increasing compliance in OA treatment', during which she will discuss some of the reasons behind poor compliance and strategies to improve compliance by owners of dogs with osteoarthritis.
Forte Healthcare’s head of technical services and marketing, Dr Lucy Chadwick said: "We are delighted to have two well-recognised experts to deliver these webinars and we’ve made sure that they will be as equally relevant for vet nurses as they are for practising vets.
"For anyone who cannot join the live screenings, the webinars will be made available to watch on demand for a limited time after they are shown."
To register for the webinars, visit: www.fortehealthcare.com/oa-2018
The clinic is being run by Liz Leece, an RCVS and EBVS Specialist in veterinary anaesthesia and analgesia, to offer bespoke pain management plans for clients.
Liz has more than 20 years’ experience in specialist anaesthesia and analgesia and has extensive experience managing dogs and cats with complex problems causing chronic pain.
Liz said: "Our pets are similar to humans in the sense that the longer they live, the greater the chance they will develop conditions causing chronic pain.
"The clinic is available for any pet referred by their primary care vet for management of chronic pain, including osteoarthritis and other orthopaedic conditions, neurological and cancer pain.
"Animals will be assessed and advice given on how the pain can be managed, including monitoring a pet’s response to different treatments and what to expect."
For more information, visit www.paragonreferrals.co.uk.
The new course is called Veterinary Science: Accelerated Graduate Entry (BVSc), and will welcome its first students in September 2019.
The school says the course responds to calls for innovation in veterinary education while upholding current best practice in adult education to support independent, self-directed, and collaborative learning.
Designed for graduate learners, the programme will see students guided through case-based, tutor-facilitated teaching and learning.
The programme is based on a collaborative approach, where students can work together to gain practical experience from BVS clinics and clinical research.
Students will be taught in new purpose-built teaching facilities at the school in Langford, North Somerset.
The Langford Campus also encompasses equine and small animal hospitals, a dairy farm, diagnostic laboratories, and farm animal, small animal and equine practices.
Professor Richard Hammond, Head of Bristol Veterinary School said: "As someone who was a graduate entry veterinary student myself, I feel passionately about providing opportunities to those who make the choice to train as a vet later in their educational journey.
"This new programme, delivered in purpose built, state-of-the-art facilities will focus on a more student-centred, case-based approach in small groups and with lots of tutor contact and support. We look forward to welcoming our first cohort of students to Bristol in September 2019".
The Privy Council has overturned an RCVS Disciplinary Committee to strike Leeds-based Dr Gary Samuel MRCVS from the Register following his conviction for theft, common assault and a public order offence at Cardiff Magistrates' Court in November 2011.
The Disciplinary Committee had agreed the sanction following a hearing in February 2013, at which it decided that Dr Samuel's conviction made him unfit to practise veterinary surgery.
Dr Samuel appealed the decision and the Privy Council heard the case on 26th March.
Dr Samuel had been sentenced by Cardiff Magistrates' Court to concurrent terms of 28 days' imprisonment for theft and common assault and 12 weeks' imprisonment for the public order offence, all suspended for 12 months. He had also been ordered to carry out 140 hours' unpaid work and to pay compensation of £75 and costs of £625. The charges related to an incident involving Dr Samuel and his neighbour, described by the Privy Council as "a spontaneous outburst in the course of an angry quarrel between neighbours", for which it felt that the Disciplinary Committee's sanction of removal from the Register was "disproportionately severe."
The Privy Council felt that, in making its decision, the Disciplinary Committee followed too closely the verdict reached by the Magistrates' Court, and did not take mitigating circumstances sufficiently into account, including whether the attack by Dr Samuel on his neighbour had been provoked by racial abuse.
Delivering the Privy Council's judgment, Lord Toulson said: "It is apparent from the reasons given by the Committee, both on the question of fitness to practise and on the question of sanction, that it was considerably influenced by the fact that the magistrates imposed a suspended prison sentence.
"Although Dr Samuel pleaded guilty to the theft of the camera and he was not in entitled to go behind his plea, it is nevertheless difficult to understand on the evidence how the prosecution would have proved that there was an intent permanently to deprive [the victim] of it. In all the circumstances, it is hard to conceive that the court would have considered that the offences truly passed the custodial threshold for a person of good character, if it had not had the power to suspend the sentence... Dr Samuel's conduct was thoroughly reprehensible, but the Board [Privy Council] does not consider that its gravity was such that it would be in the interests of the public now to remit the case to the Committee".
Dr Gary Samuel will not now be removed from the Register
The Privy Council's judgment can be read in full at http://jcpc.uk/decided-cases/index.html
Intervet/Schering-Plough Animal Health has launched a new oxytetracycline spray which the company says offers more accurate antibiotic delivery whether the can is used in an upright or inverted position.
Alasdair King MRCVS, Intervet/Schering-Plough Animal Health veterinary manager, says new Engemycin Spray has been developed specifically to address problems reported with traditional aerosol cans:
"Antibiotic sprays are used widely, yet they can become a practical nuisance to both vets and farmers simply because many cans do not perform satisfactorily. All too frequently the nozzle leaks or detaches, the spray pattern is irregular - particularly if the can is held upside down as it so often needs to be - or the valve clogs before the can is empty. This can be a source of great frustration to users, but new Engemycin Spray overcomes all these problems."
Intervet/Schering Plough says Engemycin Spray combines a unique, quick-drying formulation with an innovative, non-clogging spray valve. The quick-drying formulation minimises wastage from the sprayed area, while the new valve - which works as well when the can is upside down - cuts spraying time and ensures more reliable and constant delivery of antibiotic. The valve is unique and designed to enable the can to fully empty.
Engemycin Spray is licensed for the treatment of foot and wound infections in cattle, sheep or pigs following surgery or physical injury. The new product is available now from wholesalers.
Novartis Animal Health UK has announced a strategic partnership with Procter & Gamble (P&G) Pet Care, maker of the Eukanuba and Iams brands.
As part of the arrangement, the Novartis sales team will start detailing P&G's pet nutrition products to veterinary practices from April 1, 2014 in the UK and at a later stage in Ireland.
Novartis says the partnership brings together two highly complementary portfolios: Novartis is a leader in pet health areas in which P&G's Eukanuba Veterinary Diets have acknowledged strong clinical formulations, specifically dermatology, nephrology, and orthopaedic conditions. The partnership is designed to offer veterinary surgeons a holistic and flexible portfolio in key canine and feline health areas, as well as increased commercial and technical support and partnership from the Novartis sales team.
Simon Harris, sales & marketing manager at Novartis said: "Novartis Animal Health already offers expertise in key companion animal diseases together with innovative veterinary medicines. Based on research done with veterinary customers, we believe nutrition also plays an important role in disease management in pets, making our strategic cooperation with P&G Pet Care a natural fit that offers real benefits to veterinarians and their patients."
Dr. Penny Watson, Senior Lecturer in Small Animal Medicine at the University of Cambridge, said: "Clinical nutrition plays a key role in patient management and is an important complement to medicine in order to achieve a successful outcome. This combination of Eukanuba Veterinary Diets and Novartis Animal Health products helps highlight the importance of dispensing clinical diets as part of a multi-modal approach to effective patient management. Additionally, high quality nutrition is also recommended by vets as part of a normal day-to-day healthy lifestyle."
The partnership will be launched at the BSAVA Congress. The two companies say they'll have a joint presence at the event to showcase the strength and versatility of the combined Novartis and P&G Pet Care portfolio to the veterinary community.
Idexx has launched Pet Resist (www.petresist.com), an online map of the levels of antibiotic resistance recorded in cats and dogs by the company over the past five years.
The map displays geographical variations in resistance to the top 10 antibiotics used in cats and dogs.
Simon Wootton, UK CAG Marketing Manager from Idexx said: "The ability to select the most appropriate antibiotic prior to testing may increase the effectiveness of treatments and reduce the number of return visits. We believe that this new service will also help prolong the effective life of existing antibiotics at a time when there is considerable pressure on the profession to reduce their use."
Pet Resist shows levels of resistance overlaid on an interactive UK map down to individual postcode areas. You enter the postcode, the antibiotic (amoxicillin, ampicillin, cefaliexn, etc) and the suspected organism (E coli, S aureus, etc), after which you'll be able to see the level of resistance based on historical data from the past five years, and use this to help choose appropriate therapies.
Simon added: "We have used results of MIC tests on over 200,000 samples submitted to Idexx to develop the database upon which the resistance levels are based. The data will be continually updated as we receive more samples at our Wetherby laboratory, further increasing the accuracy and value of the service to vets and their clients."